Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
BPC-157 is still a research-stage compound with limited human clinical evidence, so the only responsible way to evaluate a product like this is to separate (1) what the company discloses and can document (testing, formulation, policies) from (2) what preclinical research suggests in animals or lab settings, and (3) what remains unproven in humans
When applied as 0.1% ophthalmic solution for up to 28-days, Thymosin Beta-4 was also effective in improving dry eye symptoms [21]
Yes, every batch is supported by a Certificate of Analysis
Expert Treatment Delivery Our highly trained medical professionals administer your treatment using precision techniques and FDA-approved products, prioritizing your comfort and safety
Presented for research literature review only Toscano V et al
Published Research on the Component Compounds GHK-Cu Genome-Wide Gene Expression Pickart et al., BioMed Research International (2015) This widely-cited review and analysis paper synthesizes the mechanistic case for GHK-Cus effects on dermal and tissue repair
